Javascript must be enabled to continue!
ANTITHROMBOTIC EFFECTS OF SULODEXIDE: A REVIEW ARTICLE
View through CrossRef
Objectives: To review the current knowledge regarding the mechanisms of action and the clinical indications of Sulodexide, a glycosaminoglycan
with established efcacy for the prevention of recurrent venous thromboembolism, with reduced bleeding risk. A critical review of the Methods:
literature regarding Sulodexide in several data sources between 1975 and 2020. A total of 481 articles were found and analyzed but only 21 articles
were considered for this review. Antithrombotic effects of Sulodexide include vas Results: cular endothelial protection, diminished platelet
aggregation in response to several stimuli, inhibition of plasma coagulation factors Xa and thrombin, enhancement of brinolysis secondary to
reducing PAI-1 and increasing of tPA, and decreased blood viscosity. Compared with other extended treatments, Sulodexide decreases mortality
and bleeding episodes. Due to its broad range of pleiotropic effects and mainly a Conclusions: ntithrombotic, Sulodexide has emerged as a
therapeutic option for the prevention of recurrent venous thromboembolism in subjects with high risk of bleeding, including elderly patients.
Title: ANTITHROMBOTIC EFFECTS OF SULODEXIDE: A REVIEW ARTICLE
Description:
Objectives: To review the current knowledge regarding the mechanisms of action and the clinical indications of Sulodexide, a glycosaminoglycan
with established efcacy for the prevention of recurrent venous thromboembolism, with reduced bleeding risk.
A critical review of the Methods:
literature regarding Sulodexide in several data sources between 1975 and 2020.
A total of 481 articles were found and analyzed but only 21 articles
were considered for this review.
Antithrombotic effects of Sulodexide include vas Results: cular endothelial protection, diminished platelet
aggregation in response to several stimuli, inhibition of plasma coagulation factors Xa and thrombin, enhancement of brinolysis secondary to
reducing PAI-1 and increasing of tPA, and decreased blood viscosity.
Compared with other extended treatments, Sulodexide decreases mortality
and bleeding episodes.
Due to its broad range of pleiotropic effects and mainly a Conclusions: ntithrombotic, Sulodexide has emerged as a
therapeutic option for the prevention of recurrent venous thromboembolism in subjects with high risk of bleeding, including elderly patients.
Related Results
#6698 THROMBOPROPHYLAXIS IN PEDIATRIC KIDNEY TRANSPLANTATION: A META-ANALYSIS
#6698 THROMBOPROPHYLAXIS IN PEDIATRIC KIDNEY TRANSPLANTATION: A META-ANALYSIS
Abstract
Background and Aims
Kidney transplant patients are at higher risk for developing renal graft thrombosis, especially in ...
Evaluating the Science to Inform the Physical Activity Guidelines for Americans Midcourse Report
Evaluating the Science to Inform the Physical Activity Guidelines for Americans Midcourse Report
Abstract
The Physical Activity Guidelines for Americans (Guidelines) advises older adults to be as active as possible. Yet, despite the well documented benefits of physical a...
[RETRACTED] Keanu Reeves CBD Gummies v1
[RETRACTED] Keanu Reeves CBD Gummies v1
[RETRACTED]Keanu Reeves CBD Gummies ==❱❱ Huge Discounts:[HURRY UP ] Absolute Keanu Reeves CBD Gummies (Available)Order Online Only!! ❰❰= https://www.facebook.com/Keanu-Reeves-CBD-G...
Perioperative/Periprocedural Antithrombotic Management in Oral Health Procedures. A Prospective Observational Study
Perioperative/Periprocedural Antithrombotic Management in Oral Health Procedures. A Prospective Observational Study
Background/Objectives: This paper evaluates the incidence of thrombotic and/or hemorrhagic adverse events within 30 days after oral health procedures (OHPs) in patients taking anti...
The Impact of Antithrombotic Therapy in Patients with De-compensated Heart Failure and Iron
The Impact of Antithrombotic Therapy in Patients with De-compensated Heart Failure and Iron
Abstract: The iron deficient anaemia is a common medical condition in patients with heart failure receiving antithrombotic therapy. Especially during the COVID19 pandemic period th...
GW24-e2334 Antithrombotic medication for primary prevention of stroke in Chinese hypertensive outpatients: a cross-sectional study
GW24-e2334 Antithrombotic medication for primary prevention of stroke in Chinese hypertensive outpatients: a cross-sectional study
Objectives
To investigate the antithrombotic application to stroke prophylaxis among hypertensive outpatients in China.
...
Antithrombin III-Independent Effect of Depolymerized Holothurian Glycosaminoglycan (DHG) on Acute Thromboembolism in Mice
Antithrombin III-Independent Effect of Depolymerized Holothurian Glycosaminoglycan (DHG) on Acute Thromboembolism in Mice
SummaryA previous study in this laboratory showed that depolymerized holothurian glycosaminoglycan (DHG) has two different antithrombin III (ATIII)-independent inhibitory effects o...
Antithrombotic Therapy in People with Hemophilia—A Narrative Review
Antithrombotic Therapy in People with Hemophilia—A Narrative Review
As the life expectancy of individuals with hemophilia continues to increase, the complexity of balancing bleeding risks and thrombotic management has become increasingly critical i...

